Business

Atossa Therapeutics to Release Final Data from Phase 2 Study of Endoxifen Administered to Breast Cancer Patients Prior to Surgery at a Webinar at 8 am Pacific Time on June 9, 2021

SEATTLE, June 07, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and

articleAtossa Therapeutics, Inc.June 7, 20215/company/atossa-genetics-inc/news/atossa-therapeutics-to-release-final-data-from-phase-2-study-of-endoxifen-administered-to-breast-cancer-patients-prior-to-surgery-at-a-webinar-at-8-am-pacific-time-on-june-9-2021
Atossa Therapeutics to Release Final Data from Phase 2 Study of Endoxifen Administered to Breast Cancer Patients Prior to Surgery at a Webinar at 8 am Pacific Time on June 9, 2021

About this update from Atossa Therapeutics, Inc.

[{"type":"text","content":"SEATTLE, June 07, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, announces that it will hold a webinar at 8 am Pacific Time on June 9, 2021 to release and discuss final data from its Phase 2 study of Endoxifen administered to breast cancer patients prior to surgery. The webinar will be attended by Dr. Steven Quay, CEO and President, Kyle Guse, CFO and General Counsel, and Dr. B. Heather Fraser, VP Clinical, Regulatory and CMC. To register to join the complimentary ZOOM-based webinar event, please visit Tribe Public LLC at ATOS.TribePublic.com. Registered participants may email questions for Atossa’s management to Tribe Public prior to the event at [email protected] or share their questions via the ZOOM chat feature during the event. Tribe Public’s Managing Member, John F. Heerdink, Jr., will host the event and relay questions to management. About Atossa Therapeutics Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious diseases with a current focus on breast cancer and COVID-19. For more information, please visit www.atossatherapeutics.com. About Tribe Public LLC Tribe Public LLC is a San Francisco, CA-based organization that hosts complimentary worldwide webinar & meeting events in the U.S. Tribe's events focus on issues that the Tribe's members care about with an emphasis on hosting management teams and experts from publicly traded companies from all sectors & financial organizations that are seeking to increase awareness of their products, progress, and plans. Tribe members primarily include Institutions, Family Offices, Portfolio Managers, Registered Investment Advisors, Accredited Investors, Sell Side Analysts, and members of media. Tribe Members are encouraged to express their interest in speakers at the Tribe Public website via the Tribe's FREE \"Wish List\" process. Visit Tribe Public's Website http://www.tribepublic.com/ to join the Tribe and express your interests today. Forward-Looking Statements Forward-looking statements in this press release, which Atossa undertakes no obligation to update, are subject to risks a...

More updates from Atossa Therapeutics, Inc.